This inventor holds 20 USPTO granted patents and 1 EPO patent, primarily in Cholesterol Inhibitors. Top assignee: Hoffmann-La Roche Inc.. Active years: 1996-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-2008
Areas of Expertise:
Title: The Innovative Contributions of Olivier Morand: A Patent Landscape
Introduction: Olivier Morand, a prominent inventor based in Hegenheim, France, has made significant strides in the field of pharmaceutical innovations. With a robust portfolio of 20 patents, Morand focuses on developing compounds that address critical health issues, primarily through his work with Hoffmann-La Roche Inc. His inventions are not only groundbreaking but also offer potential solutions for various diseases.
Latest Patents: Among Morand's latest contributions are two noteworthy patents. The first patent pertains to heteroaromate OSC inhibitors, which are promising compounds for treating diseases associated with 2,3-oxidosqualene-lanosterol cyclase. These diseases include hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, and tumors, among others. The second patent involves aminoalkylamide substituted cyclohexyl derivatives, which also concentrate on treating similar conditions while aiming to improve glucose tolerance and tackle diabetes.
Career Highlights: Throughout his career at Hoffmann-La Roche Inc., Olivier Morand has shown a strong commitment to innovation in the pharmaceutical industry. His array of patents showcases his dedication to finding novel therapeutic approaches and enhancing patient care. His work has significant implications for many prevalent health conditions, illustrating the importance of continued research and development in medicine.
Collaborations: Morand collaborates with esteemed colleagues such as Johannes Aebi and Henrietta Dehmlow, which enriches his research endeavors. This teamwork fosters a collaborative environment that nurtures creativity and enhances the overall quality of their innovative contributions.
Conclusion: Olivier Morand's extensive patent portfolio and innovative inventions illustrate his pivotal role in the pharmaceutical landscape. His focus on addressing critical health challenges through scientific advancements at Hoffmann-La Roche Inc. positions him as a key figure in the realm of medical inventions. As his work continues to evolve, it holds great promise for the future of healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile